Cardiol Therapeutics Inc. (TSX:CRDL)
Canada · Delayed Price · Currency is CAD 1.850
-0.080 (-4.15%)
Apr 8, 2026, 12:59 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of CAD 215.91 million as of April 8, 2026. Its market cap has increased by 54.73% in one year.
Market Cap
215.91M
Enterprise Value
194.62M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.85
Market Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from 94.32M to 215.91M, an increase of 128.93%. That is a compound annual growth rate of 12.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 217.03M | 66.48% |
| Dec 31, 2025 | 130.36M | -13.65% |
| Dec 31, 2024 | 150.97M | 110.34% |
| Dec 29, 2023 | 71.77M | 63.28% |
| Dec 30, 2022 | 43.96M | -69.05% |
| Dec 31, 2021 | 142.02M | 55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 288.85M |
| Aurora Cannabis | 271.64M |
| Organigram Global | 261.77M |
| Auxly Cannabis Group | 182.66M |
| Cannara Biotech | 175.83M |
| BioSyent | 171.00M |
| Charlotte's Web Holdings | 162.88M |
| HLS Therapeutics | 137.60M |